Acumen Pharmaceuticals, Inc. · NASDAQ:ABOS
Porter Derrell sold 32,300 Acumen Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 15 to Jun 17, 2026 · Filed Jun 17, 2026
From Jun 15 to Jun 17, 2026, Porter Derrell (Director) sold 32,300 Acumen Pharmaceuticals, Inc. shares at an average US$2.33 for US$75,388, leaving 35,500 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 32,300 shares
- Price
- US$2.33 average (US$2.33 to US$2.35)
- Value
- US$75,388
- Holding after
- 35,500 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Option exercise | 6,460 | US$1.07 | 54,760 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 6,460 | US$2.35 | 48,300 | Direct |
| Jun 16, 2026 | Common Stock | Sale | 12,800 | US$2.33 | 35,500 | Direct |
| Jun 17, 2026 | Common Stock | Option exercise | 13,040 | US$1.07 | 48,540 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 13,040 | US$2.33 | 35,500 | Direct |
Source
Related
- Acumen Pharmaceuticals, Inc.
- Porter Derrell
- Acumen Pharmaceuticals, Inc. shareholders
- Form 4 · Porter Derrell · Jun 5, 2026
- Form 4 · Fountain Nathan B · Jun 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 5, 2026
- Form 4 · Fountain Nathan B · Jun 5, 2026
- Form 4 · Drapkin Kimberlee C · Jun 5, 2026
- Form 4 · Stalfort John A III · Jun 5, 2026